Comments
Loading...
Atara Biotherapeutics (ATRA) Forecast
NewsEarningsAtara Biotherapeutics (ATRA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAtara Biotherapeutics (NASDAQ:ATRA) Stock Quotes, Forecast and News Summary
Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atara Biotherapeutics (ATRA) stock?
You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.
Who are Atara Biotherapeutics (ATRA) competitors?
Other companies in Atara Biotherapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), PepGen (NASDAQ:PEPG), Barinthus Biotherapeutics (NASDAQ:BRNS) and OS Therapies (AMEX:OSTX).
What is the forecast, or price target, for Atara Biotherapeutics (ATRA) stock?
Atara Biotherapeutics has a consensus price target of $15.15.
What is the current price for Atara Biotherapeutics (ATRA)?
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $7.3 last updated February 21, 2025 at 5:50 AM EST.
Does Atara Biotherapeutics (ATRA) pay a dividend?
There are no upcoming dividends for Atara Biotherapeutics.
When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?
Atara Biotherapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Atara Biotherapeutics (ATRA) going to split?
There is no upcoming split for Atara Biotherapeutics.
What sector and industry does Atara Biotherapeutics (ATRA) operate in?
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.